Skip to main content
Premium Trial:

Request an Annual Quote

People in the News at NIH's 'All of Us' Program, Quantum-Si, Singular Genomics, More

All of Us Research Program: Andrea Ramirez, Rachele Peterson

Andrea Ramirez has been appointed as chief data officer and Rachele Peterson as chief of staff for the National Institutes of Health's All of Us Research Program.

Ramirez was previously a physician scientist at Vanderbilt University Medical Center, where she also led the data science team at the All of Us Data and Research Center. She holds a medical degree from Duke University School of Medicine, an M.S. in clinical investigation from Vanderbilt University, and a B.S. in biochemistry from North Carolina State University.

Peterson comes to All of Us from Vibrent Health, where she was senior director of clinical research and served as principal investigator for multiple projects related to Vibrent's work with All of Us. Prior to that, she was the executive director and principal investigator of the University of Arizona and Banner Health All of Us Health Care Provider Organization. She holds an M.S. and an executive MBA from Arizona State University and a B.A. in public policy from the University of North Carolina at Chapel Hill.


Quantum-Si: Patrick Schneider, Michael McKenna

Quantum-Si has named Patrick Schneider as president and chief operating officer, succeeding Michael McKenna who will remain as executive vice president, product development and operations.

Schneider was previously senior vice president of strategy, business development and innovation, and chair of the life science innovation board at MilliporeSigma. Before that he was vice president of R&D, business development and scientific affairs at Serologicals. He also cofounded Genome Biosciences and Integrated Cell Technologies.


Singular Genomics Systems: David Barker, Lawrence Fong, David Ledbetter, Elaine Mardis, Daniel Shoemaker

Singular Genomics Systems has formed a scientific advisory board comprising David Barker, Lawrence Fong, David Ledbetter, Elaine Mardis, and Daniel Shoemaker.

Barker, also a member of the firm's board of directors, is a former Illumina chief scientific officer. He is also board chair at Bionano Genomics. He holds a doctorate in biochemistry from Brandeis University.

Fong is a professor of cancer biology at the University of California, San Francisco and codirector of the Parker Institute of Cancer Immunotherapy. He holds an M.D. from Stanford University.

Ledbetter is chief clinical and research officer at Unified Patient Network. He holds a doctorate from the University of Texas-Austin.

Mardis, also a board member, is coexecutive director of the Institute of Genomic Medicine at Nationwide Children's Hospital. A former president of the American Association for Cancer Research, she holds a doctorate in chemistry and biochemistry from the University of Oklahoma.

Shoemaker is formerly CSO at Fate Therapeutics. He holds a doctorate in biochemistry from Stanford.


For additional recent items on executive appointments, promotions, and departures in omics and molecular diagnostics, please see the People in the News page on our website.

Filed under

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.